APAC Q-PCR Reagents Market - Industry Trends And Forecast To 2029
Asia-Pacific q-PCR reagents market is projected to register a substantial CAGR of 5.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2019, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Asia-Pacific Q-PCR Reagents Market, By Detection Type (Dye -Based Reagents and Probe -Based Reagents), Assay Type (Qpcr Singleplex Test/Assay and Qpcr Multiplex Test/Assay), Plexity (Dye -Based Reagents and Probe -Based Reagents), Packaging Type (Kits and Master Mixes), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification and Virus Detection), Application (Diagnostics, Research and Forensic), End User (Hospital & Diagnostic Centers, Forensic Laboratories, Research & Academic Institute, Clinical Research Organization, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (China, India, Japan, Australia South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific q-PCR reagents market are:
• Increasing demand for q-PCR reagents
• Increasing disposable income
Market Players:
The key market players for Asia-Pacific q-PCR reagents market are listed below:
• Norgen Biotek Corp
• Takara Holdings Inc.
• Enzo Biochem Inc
• Qiagen
• PCR Biosystems
• Tonbo Biosciences
• Quantabio,
• Merck KgaA
• Kaneka Eurogentec S.A
• Promega Corporation
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook